Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Leprfa/IzmDmcr rats as a new model of metabolic syndrome

Hypertension Research

Volumn 31, Issue 5, 2008, Pages 1021-1031

  Ueno, Takahiro ^a   Takagi, Hiroto ^a   Fukuda, Noboru ^a,b   Takahashi, Atsuhiko ^a   Yao, En Hui ^a   Mitsumatra, Masako ^a   Hiraoka Yamamoto, Junko ^a   Ikeda, Katsumi ^c   Matsumoto, Koichi ^a   Yamori, Yukio ^d  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^d International Center for Research on Primary Prevention of Cardiovascular Diseases   (Japan)

Author keywords

Congenic rat; Hyperlipidemia; Hypertension; Insulin resistance; Metabolic syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CATHEPSIN K; DNA; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HEME OXYGENASE 1; INSULIN; LIPID; MESSENGER RNA; METALLOTHIONEIN II; PLATELET DERIVED GROWTH FACTOR A; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; VOLTAGE DEPENDENT ANION CHANNEL 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; CAROTID ARTERY; CELL CULTURE; CONGENIC STRAIN; CONTROLLED STUDY; CORONARY ARTERY; DIET RESTRICTION; DISEASE MODEL; DISEASE SEVERITY; DNA SYNTHESIS; DOWN REGULATION; DYSLIPIDEMIA; GENE IDENTIFICATION; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KIDNEY CORTEX; MEDICAL RESEARCH; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NONHUMAN; OBESITY; PANCREAS ISLET CELL HYPERPLASIA; PHENOTYPE; RAT; RENAL ARTERY; SMOOTH MUSCLE FIBER; STEADY STATE; STRAIN DIFFERENCE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT; ZUCKER RAT;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CARDIOVASCULAR SYSTEM; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPIDIDYMIS; GENE EXPRESSION PROFILING; HYPERTENSION; INSULIN; INSULIN RESISTANCE; KIDNEY CORTEX; MALE; METABOLIC SYNDROME X; MUSCLE, SMOOTH, VASCULAR; PANCREAS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; RATS, INBRED WKY; RATS, ZUCKER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 46049104701     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1021     Document Type: Article

References (46)

1. Landsberg L: Insulin resistance and hypertension. Clin Exp Hypertens 1999; 21: 885-894.
2. Rett K: The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Diabetes Obes Metab 1999; 1 (Suppl 1): S8-S16.
3. Matsuzawa Y, Funahashi T, Nakamura T: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999; 892: 146-154.
4. Eschwege E: The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes Metab 2003; 29: 6S19-6S27.
5. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM: Renin-angiotensin system and cardiovascular risk. Lancet 2007;369: 1208-1219.
6. Hiraoka-Yamamoto J, Nara Y, Yasui N, Onobayashi Y, Tsuchikura S, Ikeda K: Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats. Clin Exp Pharmacol Physiol 2004; 31: 107-109.
7. Raij L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dah1 rats. Kidney Int 1984; 26: 137-143.
8. Qian X, Jin L, Grande JP, Lloyd RV: Transforming growth factor-beta and p27 expression in pituitary cells. Endocrinology 1996; 137: 3051-3060.
9. Fukuda N, Kishioka H, Satoh C, et al: Role of long-form PDGF A-chain in the growth of vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens 1997; 10: 1117-1124.
10. el-Husseini AE, Paterson JA, Myal Y, Shiu RP: PCR detection of the rat brain basic fibroblast growth factor (bFGF) mRNA containing a unique 3′ untranslated region. Biochim Biophys Acta 1992; 1131: 314-316.
11. Hoof T, Riordan JR, Tummler B: Quantitation of mRNA by the kinetic polymerase chain reaction assay: a tool for monitoring P-glycoprotein gene expression. Anal Biochem 1991; 196: 161-169.
12. Baumbach GL, Walmsley JG, Hart MN: Composition and mechanics of cerebral arterioles in hypertensive rats. Am J Pathol 1988; 133: 464-471.
13. Ogata J, Fujishima M, Tamaki K, Nakatomi Y, Ishitsuka T, Omae T: Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. I. A light- and electron-microscopic study of the brain. Acta Neuropathol (Berl) 1980; 51: 179-184.
14. Takaya K, Ogawa Y, Isse N, et al: Molecular cloning of rat leptin receptor isoform complementary DNA - dentification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 1996; 225: 75-83.
15. Zucker TF, Zucker LM: Fat accretion and growth in the rat. Obes Res 1996; 4: 102-108.
16. Larsson LI, Boder GB, Shaw WN: Changes in the islets of langerhans in the obese Zucker rat. Lab Invest 1977; 36: 593-598.
17. Milburn JL Jr, Hirose H, Lee YH, et al: Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995; 270: 1295-1299.
18. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP: Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/ angiotensin II crosstalk. J Clin Invest 1997; 100: 2158-2169.
19. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR: Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 1996; 93: 12490-12495.
20. Fukuda N, Hu WY, Teng J, et al: Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 2002; 163: 229-239.
21. Fukuda N, Satoh C, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K: Endogenous angiotensin II suppresses insulin signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 2001; 19: 1651-1658.
22. Higashiura K, Ura N, Miyazaki Y, Shimamoto K: Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension. J Hum Hypertens 1999; 13 (Suppl 1): S71-S74.
23. Shimamoto K, Ura N, Nakagawa M, et al: The mechanisms of the improvement of insulin sensitivity by angiotensin converting enzyme inhibitor. Clin Exp Hypertens 1996; 18: 257-266.
24. Bahadir O, Aydin S, Caylan R: The effect on the middle-ear cavity of an absorbable gelatine sponge alone and with corticosteroids. Eur Arch Otorhinolaryngol 2003; 260: 19-23.
25. Yamaguchi K, Ura N, Murakami H, et al: Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle. Hypertens Res 2005; 28: 773-778.
26. Fukuda N, Nakayama M, Jian T, et al: Leukocyte angiotensin II levels inpatients with essential hypertension: relation to insulin resistance. Am J Hypertens 2003; 16: 129-134.
27. Cai H, Li Z, Dikalov S, et al: NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 2002; 277: 48311-48317.
28. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148.
29. Moriki N, Ito M, Seko T, et al: RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 263-270.
30. Negishi H, Ikeda K, Sagara M, Sawamura M, Yamori Y: Increased oxidative DNA damage in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1999; 26: 482-484.
31. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG: Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999; 17: 1949-1953.
32. Verma S, Leung YM, Yao L, Battell M, Dumont AS, McNeill JH: Hyperinsulinemia superimposed on insulin resistance does not elevate blood ptessure. Am J Hypertens 2001; 14: 429-432.
33. Fukuda N, Hu WY, Satoh C, et al: Contribution of synthetic phenotype on the enhanced angiotonsin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 1999; 17: 1099-1107.
34. Fukuda N, Satoh C, Hu WY, et al: Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1999; 19: 1210-1217.
35. Hu WY, Fukuda N, Kanmatsuse K: Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats. J Hypertens 2002; 20: 1323-1333.
36. Hu WY, Fukuda N, Satoh C, et al: Phenotypic modulation by fibronectin enhances the angiotensin III-generating system in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 1500-1505.
37. Satoh C, Fukuda N, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K: Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 2001; 37: 108-118.
38. Rodriguez S, Gaunt TR, Day IN: Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease. Hum Genet 2007; 122: 1-21.
39. Beattie JH, Wood AM, Newman AM, et al: Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci USA 1998; 95: 358-363.
40. Hurowitz EH, Melnyk JM, Chen YJ, Kouros-Mehr H, Simon MI, Shizuya H: Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes. DNA Res 2000; 7: 111-120.
41. Calabrese V, Boyd-Kimball D, Scapagnini G, Butterfield DA: Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. In Vivo (Athens, Greece) 2004; 18: 245-267.
42. Katzmarzyk PT, Rankinen T, Perusse L, et al: Linkage and association of the sodium potassium-adenosine triphosphatase alpha2 and beta1 genes with respiratory quotient and resting metabolic rate in the Quebec Family Study. J Clin Endocrinol Metab 1999; 84: 2093-2097.
43. Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K: Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta 1992; 212: 89-102.
44. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC: A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999; 19: 1262-1270.
45. Blachly-Dyson E, Zambronicz EB, Yu VVH, et al: Cloning and functional expression in yeast of two human isoforms of the outer mitochondrial membrane channel, the voltage-dependent anion channel. J Biol Chem 1993; 268: 1835-1841.
46. Huq AH, Lovell RS, On CN, Beaudet AL, Craigen WJ: X-linked glycerol kinase deficiency in the mouse leads to growth retardation, altered fat metabolism, autonomous glucocorticoid secretion and neonatal death. Hum Mol Genet 1997; 6: 1803-1809.